KEFLIN Drug Patent Profile
✉ Email this page to a colleague
When do Keflin patents expire, and when can generic versions of Keflin launch?
Keflin is a drug marketed by Lilly and is included in two NDAs.
The generic ingredient in KEFLIN is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for KEFLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 150 |
Patent Applications: | 4,272 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KEFLIN at DailyMed |
US Patents and Regulatory Information for KEFLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | KEFLIN | cephalothin sodium | INJECTABLE;INJECTION | 050482-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | KEFLIN | cephalothin sodium | INJECTABLE;INJECTION | 050482-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | KEFLIN | cephalothin sodium | INJECTABLE;INJECTION | 050482-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | KEFLIN | cephalothin sodium | INJECTABLE;INJECTION | 050482-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |